FACTS ABOUT AZELAPRAG PEPTIDE REVEALED

In December, BioAge declared a multi-12 months investigation collaboration with Novartis to recognize and validate novel therapeutic targets on the intersection of getting old biology and training, combining BioAge's longitudinal human getting old datasets with Novartis know-how in training biology.Apelin receptor agonists are now being pursued for